Group Conflict, Kratom Disclosure, and a No-Substance Contract
Andre, 41, is 21 days abstinent from alcohol and cocaine and attends an intensive outpatient group. During group, a peer gently notes that Andre has been quiet. Andre erupts: 'You don't know me-I've been clean three weeks, that's more than anyone here.' He then admits he has been using kratom daily to 'take the edge off' and did not think it counted. Two group members laugh; one says kratom is 'natural.' The group has eight members, 90 minutes, and a no-substance-use contract. The group norm is confidentiality and mutual respect. Andre has one psychiatric hospitalization for depression five years ago and denies current suicidal ideation. He is mandated to treatment by drug court and has a court date in two weeks. He calms down but avoids eye contact.
1. What do you say and do in the moment to manage the group and address Andre's disclosure?
Read the worked answer
First, safety and group norms. I would calmly thank the peer for noticing, then set a boundary: no one is required to perform recovery, and no one gets to rank who is 'cleanest.' I would reflect Andre's anger without endorsing the attack: 'It sounds like being watched feels like being judged.' I would not debate him in front of the group. I would acknowledge the kratom disclosure as important and say we will talk about it individually, because it affects his contract, court status, and safety. I would ask the group to return to their own process and not laugh or give advice. After group, I would meet Andre briefly to assess use, withdrawal, mood, and suicide risk. In the moment, the counselor's job is to lower shame, maintain safety, and keep the group therapeutic rather than to extract a confession.
2. What clinical and ethical issues does the kratom use raise, and how do you assess it?
Read the worked answer
Kratom is not typically detected on standard urine drug screens, so a negative screen does not prove abstinence; the disclosure is clinically meaningful. It can produce dependence, withdrawal, and interactions, and it may be used to self-manage anxiety or opioid-like cravings. I would take a detailed history: dose, frequency, source, last use, withdrawal symptoms, spending, and whether it is a substitute for cocaine or alcohol. I would update the treatment plan and consider medical consultation. Ethically, I must not minimize it to protect Andre from court consequences, nor punish him for honesty. I would explain limits of confidentiality with drug court and what I am required to report. The no-substance contract should be applied consistently, but the first response is assessment and treatment, not discharge. I would also address the group's laughter as a norm issue.
3. What follow-up and documentation steps do you take after group?
Read the worked answer
I would document the group interaction objectively: the peer's comment, Andre's statement, the kratom disclosure, and my interventions, avoiding labels. I would schedule an individual session within 24 to 48 hours, complete a focused assessment, and screen for depression and suicide risk again despite his denial. I would consult my supervisor about the drug court reporting requirement and the no-substance contract. With Andre's consent, I would coordinate with his drug court case manager and consider a medical referral for kratom cessation. I would also follow up with the group next session about respect and confidentiality. If he discloses imminent risk, I would follow emergency procedures. Documentation should show clinical reasoning and the plan, not just that he 'admitted using kratom.' Follow-up also includes reviewing whether the group is the right fit if he is being scapegoated.